RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NRXP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

NRx Pharmaceuticals, Inc. stock price ended at $0.530 on Wednesday, after gaining 2.71%.
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 18, 2024 Gain 2.91% PDF

The NRx Pharmaceuticals, Inc. stock price gained 2.71% on the last trading day (Wednesday, 27th Mar 2024), rising from $0.516 to $0.530. During the last trading day the stock fluctuated 7.84% from a day low at $0.510 to a day high of $0.550. The price has risen in 6 of the last 10 days and is up by 14.47% over the past 2 weeks. Volume fell on the last day by -197 thousand shares and in total, 342 thousand shares were bought and sold for approximately $181.21 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 17.32% during the next 3 months and, with a 90% probability hold a price between $0.388 and $0.85 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NRXP Signals & Forecast

The NRx Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.515 and $0.490. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, March 14, 2024, and so far it has risen 24.41%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for NRx Pharmaceuticals, Inc. stock

NRx Pharmaceuticals, Inc. finds support from accumulated volume at $0.520 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0400 between high and low, or 7.84%. For the last week the stock has had daily average volatility of 11.37%.

Our recommended stop-loss: $0.510 (-3.70%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (NRXP) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect NRx Pharmaceuticals, Inc. to open at $0.530, and during the day (based on 14 day Average True Range), to move between $0.457 and $0.603, which gives a possible trading interval of +/-$0.0726 (+/-13.70%) up or down from last closing price. If NRx Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 27.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.520 (1.89%) than the resistance at $0.560 (5.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NRx Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NRx Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 2.939 Buy Candidate Unchanged

Predicted Opening Price for NRx Pharmaceuticals, Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.530 ( 0%) $0.530

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NRXP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.570 7.55 %
R2 0.555 4.66 %
R1 0.545 2.88 %
Current price: 0.530
Support S1 0.515 -2.88 %
S2 0.505 -4.66 %
S3 0.490 -7.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.659 24.34 %
R2 0.613 15.74 %
R1 0.560 5.66 %
Current price 0.530
Support S1 0.520 -1.89%
S2 0.439 -17.09%
S3 0.438 -17.34%

FAQ

What is the symbol for NRx Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for NRx Pharmaceuticals, Inc. is NRXP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NRx Pharmaceuticals, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NRx Pharmaceuticals, Inc. stock to perform well in the short-term.

How to buy NRx Pharmaceuticals, Inc. Stock?
NRx Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NRx Pharmaceuticals, Inc. Stock.

What's the current price of NRx Pharmaceuticals, Inc. Stock?
As of the end of day on the 2024-03-27, the price of an NRx Pharmaceuticals, Inc. (NRXP) share was $0.530.

What is the 52-week high and low for NRx Pharmaceuticals, Inc. Stock?
The 52-week high for NRx Pharmaceuticals, Inc. Stock is $1.20 and the 52-week low is $0.221.

What is the market capitalization of NRx Pharmaceuticals, Inc. Stock?
As of the 2024-03-27, the market capitalization of NRx Pharmaceuticals, Inc. is 47.692M.

When is the next earnings date for NRx Pharmaceuticals, Inc.?
The upcoming earnings date for NRx Pharmaceuticals, Inc. is Mar 28, 2024.
Click to get the best stock tips daily for free!

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals. NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal... NRXP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT